EP Patent

EP0480189A1 — Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances

Assigned to Altergon SA · Expires 1992-04-15 · 34y expired

What this patent protects

Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances chosen from the group consisting of cresol derivatives, hexetidine, sulfadiazine silver and sulfadiazine zinc salt for the treatment of sores, ulcerations and burns.

USPTO Abstract

Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances chosen from the group consisting of cresol derivatives, hexetidine, sulfadiazine silver and sulfadiazine zinc salt for the treatment of sores, ulcerations and burns.

Drugs covered by this patent

Patent Metadata

Patent number
EP0480189A1
Jurisdiction
EP
Classification
—
Expires
1992-04-15
Drug substance claim
No
Drug product claim
No
Assignee
Altergon SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.